Firm Individuals
Jan van de Winkel – Co-Founder, President & CEO
Tahamtan Ahmadi – Govt VP, Chief Medical Officer & Head of Experimental Medicines
Brad Bailey
Anthony Pagano – Govt VP & CFO
Judith Klimovsky – Govt VP & Chief Growth Officer
Convention Name Individuals
Jonathan Chang – Leerink Companions LLC, Analysis Division
Michael Schmidt – Guggenheim Securities, LLC, Analysis Division
Xian Deng – UBS Funding Financial institution, Analysis Division
Qize Ding – Rothschild & Co Redburn, Analysis Division
Rajan Sharma – Goldman Sachs Group, Inc., Analysis Division
Yaron Werber – TD Cowen, Analysis Division
Asthika Goonewardene – Truist Securities, Inc., Analysis Division
Matthew Phipps – William Blair & Firm L.L.C., Analysis Division
Victor Floch – BNP Paribas, Analysis Division
Zain Ebrahim – JPMorgan Chase & Co, Analysis Division
Charlie Haywood – BofA Securities, Analysis Division
Presentation
Operator
Whats up, and welcome to the Genmab First Half 2025 Monetary Outcomes Convention Name. As a reminder, this convention name is being recorded. Throughout this phone convention, chances are you’ll be offered with forward-looking statements that embody phrases similar to believes, anticipates, plans or expects. Precise outcomes might differ materially, for instance, on account of delayed or unsuccessful improvement tasks. Genmab will not be underneath any obligation to replace statements relating to the long run nor to substantiate such statements in relation to precise outcomes, except that is required by legislation. Please additionally be aware that Genmab might maintain your private information as indicated by you as a part of our Investor Relations outreach actions in an effort to replace you on Genmab going ahead. Please check with our web site for extra info on Genmab and our privateness coverage.
I’d now like handy the convention over to your first speaker at present, Jan van de Winkel. Please go forward.
Jan van de Winkel
Co-Founder, President & CEO
Whats up, and